Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AT&T Wireless has Issued the Following Statement in Response to Met Life Claims.


Business Editors

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Feb. 1, 2002

Last time we checked, everyone is still free to use the thirteenth letter of the alphabet alphabet [Gr. alpha-beta, like Eng. ABC], system of writing, theoretically having a one-for-one relation between character (or letter) and phoneme (see phonetics). Few alphabets have achieved the ideal exactness. , "m." MetLife's claims are utterly without merit.

AT&T Wireless and MetLife offer entirely unrelated products and services. We offer wireless products and services, while they offer insurance and financial services The examples and perspective in this article or section may not represent a worldwide view of the subject.
Please [ improve this article] or discuss the issue on the talk page.
. As such, there isn't the remotest chance that AT&T Wireless' use of "mLife" could in any way confuse con·fuse  
v. con·fused, con·fus·ing, con·fus·es

v.tr.
1.
a. To cause to be unable to think with clarity or act with intelligence or understanding; throw off.

b.
 consumers or dilute di·lute
v.
To reduce a solution or mixture in concentration, quality, strength, or purity, as by adding water.

adj.
Thinned or weakened by diluting.
 MetLife's brand. We are confident that the judge will rule in our favor. We have invested millions of dollars and months of efforts in our "mlife" brand campaign, which will be showcased in this Sunday's SuperBowl.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 1, 2002
Words:116
Previous Article:Microchip Technology to Present at the Goldman, Sachs & Co. Technology Investment Symposium.
Next Article:UPDATE: FDA Approves Amgen's Neulasta for Serious and Frequent Chemotherapy Side Effect.
Topics:



Related Articles
Working out the Risks.
No Strings Attached.
ACCUSED TEACHER LOSES JOB.
Processing of R&D claims: January 2002.
ARABS-ISRAEL - May 29 - Sharon Seeks Response To Latest Attacks.
TEI member comments on the proposed IRS process to manage claims: May 2003.
The insurance industry goes mobile: if "bureaucracy," "inefficiency," and "slower than molasses" come to mind when you think about insurance...
IRS initiatives to decrease audit cycle times - good ideas that need more work.
NZNO's stand on enrolled nurses provokes outrage.
Wireless laptops for faculty: boon or bane?

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles